581
Views
11
CrossRef citations to date
0
Altmetric
Clinical Studies

Acute renal failure after myeloablative allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and relationship with the quantity of transplanted cells

, , , , , , , , & show all
Pages 547-554 | Received 07 Dec 2009, Accepted 07 Feb 2010, Published online: 20 May 2010

REFERENCES

  • Zager RA, O'Quigley J, Zager BK, Acute renal failure following bone marrow transplantation: A retrospective study of 272 patients. Am J Kidney Dis. 1989;13(3):210–216.
  • Zager RA. Acute renal failure in the setting of bone marrow transplantation. Kidney Int. 1994;46:1443–1458.
  • Gruss E, Bernis C, Tomas JF, Acute renal failure in patients following bone marrow transplantation: Prevalence, risk factors and outcome. Am J Nephrol. 1995;15(6):473–479.
  • Parikh CR, McSweeney PA, Korular D, Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int. 2002;62(2):566–573.
  • Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest. 2003;112(1):42–49.
  • Duffield JS, Park KM, Hsiao LL, Restoration of tubular epithelial cells during repair of the post-ischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest. 2005;115:1743–1755.
  • Toegel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol. 2005;289:F31–F42.
  • Lin F, Cordes K, Li L, Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol. 2003;14(5):1188–1199.
  • Imberti B, Morigi M, Tomasoni S, Insulin-like growth factor-1 sustains stem cell-mediated renal repair. J Am Soc Nephrol. 2007;18:2921–2928.
  • Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry: International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5(3):213–226.
  • Deleve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (venocclusive disease). Semin Liver Dis. 2002;22:27–41.
  • Parikh CR, Coca SG. Acute renal failure in hematopoietic cell transplantation. Kidney Int. 2006;69:430–435.
  • Mehta RL, Kellum JA, Shah SV, Acute kidney injury network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
  • Star RA. Treatment of acute renal failure. Kidney Int. 1998;54:1817–1831.
  • Kelly KJ, Molitoris BA. Acute renal failure in the new millennium: Time to consider combination therapy. Semin Nephrol. 2000;20:4–19.
  • Lagasse E, Connors H, Al-Dhalimy M, Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229–1234.
  • Orlic D, Kajstura J, Chimenti S, Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–705.
  • Okamoto R, Yajima T, Yamazaki M, Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med. 2002;8:1011–1017.
  • Shimizu K, Sugiyama S, Aikawa M, Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med. 2001;7:738–741.
  • Takahashi T, Kalka C, Masuda H, Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434–438.
  • Poulsom R, Forbes SJ, Hodivala-Dilke K, Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol. 2001;195:229–235.
  • Nash RA, Antin JH, Karanes C, Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood. 2000;96:2062–2068.
  • Parikh CR, Schrier RW, Storer B, Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. Am J Kidney Dis. 2005;45:502–509.
  • Parikh CR, McSweeney PA, Schrier RW. Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int. 2005;67:1999–2005.
  • Parikh CR, Sandmaier BM, Storb RF, Acute renal failure after nonmyeloablative hematopoietic cell transplantation. J Am Soc Nephrol. 2004;15:1868–1876.
  • Merouani A, Shpall EJ, Jones RB, Archer PG, Schrier RW. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int. 1996;50:1026–1031.
  • Fadia A, Casserly LF, Sanchorawala V, Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int. 2003;63:1868–1873.
  • Rao PS. Nephrotic syndrome in patients with peripheral blood stem cell transplant. Am J Kidney Dis. 2005;45:780–785
  • Panoskaltsis-Mortari A, Price A, Hermanson JR, In vivo imaging of graft-versus-host-disease in mice. Blood. 2004;103:3590–3598.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.